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By the use of a mouse model, the enteropathic effects of the simian immunodeficiency virus (SIV) surface unit (SU)
envelope glycoprotein were explored. Purified SU (0.01–0.45 nmol) was administered intraperitoneally to 6- to 8-day-old
mouse pups and induced a dose-dependent diarrheal response. Surgical introduction of SU into adult mouse intestinal loops
revealed fluid accumulation without histological alterations and SU-treated unstripped intestinal mucosa induced chloride
(Cl2) secretory currents in Ussing chambers. Similarly to rotavirus NSP4, the first described viral enterotoxin, SU induced a
transient increase in intracellular calcium levels and increased inositol 1,4,5-triphosphate (IP3) levels in HT-29 cells. These
data indicate the calcium response is mediated by IP3. The presence of diarrhea and fluid accumulation within intestinal loops
in the absence of histological alterations and induction of Cl2 secretory currents demonstrate that SIV contains an
enterotoxic domain localized within SU and is the second viral enterotoxin described. © 2000 Academic Press
Key Words: calcium mobilization; chloride secretion; diarrhea; envelope glycoprotein; SIV; viral enterotoxin.
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Simian immunodeficiency virus (SIV4) is a good model
or studying human immunodeficiency virus (HIV) infec-
ion, pathogenesis, and progression to disease (Veazey
t al., 1998; Desrosiers and Ritter, 1989; Daniel et al.,
985). SIV disease in macaques is comparable to human
cquired immunodeficiency syndrome (AIDS) and in-
uces similar pathological and morphological changes
n the intestinal mucosa (Heise et al., 1991, 1993a; Kotler
et al., 1984; Ullrich et al., 1989; Letvin et al., 1985; Kurtz et
l., 1985; Nelson et al., 1988; Kaup et al., 1998).
SIV infects mononuclear cells throughout the gastro-
ntestinal (GI) tract of rhesus macaques (Heise et al.,
993a,b) and SIV-infected macaques have infected mac-
ophage and T lymphocytes in gut-associated lymphoid
issue as early as 1 week postinfection (Heise et al.,
994). Further, CD41 T lymphocytes localized in the GI
ract are depleted as early as 7 days post-SIV infection
Veazey et al., 1998; Kewenig et al., 1999). Others report
he GI tract is a primary target for SIV infection (Veazey et
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erda; SIV, simian immunodeficiency virus; SU, surface unit; wt, wild-
ype baculovirus.
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250l., 1998; Kuhn et al., 1997; Coue¨del-Courteille et al., 1997;
mit-McBride et al., 1998; Heise et al., 1993b). The GI
ract contains a majority of the lymphoid tissue in the
ody, including a large population of activated-memory T
ymphocytes, the cell subset in which HIV replicates
ost efficiently (Veazey et al., 1998; Kraehenbuhl and
eutra, 1992; Zeitz et al., 1988; Cerf-Bensussan and Guy-
rand, 1991). In addition, galactosylceramide (GalCer) is
glycosphingolipid that is expressed in intestinal tis-
ues and mediates HIV-1 gp120 binding via a domain in
he V3 loop (Hammache et al., 1998; Bhat et al., 1991;
antini et al., 1993; Cook et al., 1994; Yahi et al., 1995).
IV-1 surface unit (SU) glycoprotein reacts preferentially
ith a hydroxylated GalCer, the predominant GalCer
species expressed by HT-29 cells, a colonic epithelial
cell line (Hammache et al., 1998). The presence of the
GalCer receptor and a large number of activated T lym-
phocytes in the intestine may facilitate infection and
replication of HIV and/or SIV.
Alterations in GI function, including chronic diarrhea,
malabsorption, and significant weight loss are devastat-
ing characteristics of infection with HIV or SIV and ac-
count for the frequently observed wasting syndrome in
AIDS or simian AIDS (SAIDS) (Ehrenpreis et al., 1992;
Heise et al., 1993a). There is a wide range of variability in
the number of cases reported in which no identifiable
enteric pathogen can be attributed to the GI dysfunction
associated with SIV/HIV infections (Heise et al., 1991,
1993b; Ullrich et al., 1989; Lambl et al., 1996). It has been
postulated that HIV infection and/or replication, the
virion, or a viral protein could be responsible for the HIV
enteropathy (Kotler et al., 1984). To determine whether
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251SIV SU IS A VIRAL ENTEROTOXINHIV/SIV has a direct role in GI dysfunction and diarrhea,
infected subjects who had no secondary infections and
suffered with chronic HIV-related diarrhea were admin-
istered antiretroviral protease inhibitors. These patients
reported a significant decrease in stool frequency, in-
crease in body weight, decrease in recurrence of diar-
rhea, and a longer mean survival time (Bini and Cohen,
1999; Foudraine et al., 1998). The fact that the GI dys-
function improves upon treatment with protease inhibi-
tors strongly suggests a direct involvement for HIV-in-
duced GI dysfunction.
The first viral enterotoxin, rotavirus NSP4, was re-
ported in 1996 and provides a basis for the isolation and
identification of other viral toxins (Ball et al., 1996). Ente-
rotoxins stimulate net secretion in ligated intestinal seg-
ments without inducing histological alterations, or stim-
ulate secretion as measured in Ussing chambers (Sears
et al., 1995; Ball et al., 1996). NSP4 mobilizes [Ca21]i via
phospholipase C activation and inositol 1,4,5-triphos-
phate (IP3) production and induces Cl
2 secretory cur-
rents (Dong et al., 1997; Ball et al., 1996). Likewise, HIV-1
SU increases [Ca21]i in cultured epithelial intestinal cells
Dayanithi et al., 1995) and induces diarrhea in mouse
ups (J. M. Ball and M. K. Estes, unpublished data).
ddition of neutralizing antibodies directed against the
3 loop ablates the increase in [Ca21]i. The response is
also diminished by pretreating the cells with neuroten-
sin, a stimulator of Cl2 secretion via IP3-mediated Ca
21
mobilization, or by administering SU immediately fol-
FIG. 1. SU induced a dose-dependent diarrhea in 6- to 8-day-old Balb
determined to be free of endotoxin. The x-axis shows the dose of SU
iarrhea. The number of animals that developed diarrhea/total number
ontrol pups were inoculated with purified PBS, wt protein, or HPIV2 F
he calculated DD50 of SU was 0.13 nmol based on the calculations olowed by neurotensin (Dayanithi et al., 1995). These data
indicate SU mobilizes [Ca21]i by a pathway common toneurotensin and NSP4. Thus, SU alone may be sufficient
to alter intestinal ion secretion and contribute to the
pathogenesis of HIV and SIV infections by acting as a
viral enterotoxin. We propose SIV SU encodes a toxic
domain that contributes to the associated GI dysfunction
and subsequent disease, in particular in the absence of
other enteric infections.
RESULTS
SU induced a dose-dependent diarrhea in a mouse
pup model
SU was inoculated intraperitoneally (IP) into 6- to
8-day-old Balb/C mouse pups and examined for diar-
rheagenic activity. Six- to 8-day-old pups were chosen
because their intestines have not yet undergone closure
(the formation of tight junctions). Closure of the intestines
reduces the uptake of materials administered IP into the
abdominal cavity (Henning and Leeper, 1984; Ball et al.,
1996). SU induced diarrhea in our mouse model when
pups were administered 0.30 nmol of protein. The diar-
rhea response to SU was specific, as administration of
an equimolar concentration of purified baculovirus wild-
type (wt) protein or 1 nmol purified human parainflu-
enza-2 virus fusion protein (HPIV2 F) expressed in a
baculovirus system and purified as SU, or the same
volume of buffer, had no effect (Fig. 1). To determine
whether the response was dose-dependent, varying
doses of SU were administered (Fig. 1). The incidence of
se pups. Each dose was administered in 50 ml of sterile PBS and was
istered and the y-axis shows the percentage of pups that developed
als given a particular dose is shown above each dose administered.
in (1 nmol), purified exactly like SIV SU, and did not develop diarrhea.
and Muench (1938)./C mou
admin
of animdiarrhea ranged from 0% to 100%, following administra-
tion of 0.01 and 0.45 nmol of purified SU, respectively.
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252 SWAGGERTY ET AL.The diarrhea dose 50 (DD50) was determined to be 0.13
mol, based on the calculations of Reed and Muench
1938). Six to 10 pups were tested at each dose of SU, 21
ups were examined with wt control or phosphate-buff-
red saline (PBS), and an additional nine pups were
dministered 1 nmol of HPIV2 F protein (greater than
wice the highest SU dose administered) and did not
evelop diarrhea. The onset of diarrhea induced by SU
as typically within 2 h post exposure and continued for
p to 8 h, occasionally for up to 12 h. When SU-treated
nimals had severe diarrhea (3 to 41), they often exhib-
ted lower body temperatures and/or were lethargic com-
ared to those animals administered the control inocu-
um.
To ensure the response was not mouse strain-spe-
TABLE 1
SIV SU-Promoted Fluid Accumulation in Adult Balb/C Mouse
Intestinal Loops
Treatment PBS HPIV2 F SIV SU
n 12 4 11
ose (nmol) 1 0.3
verage weight (g)
per length (cm) 0.0467 0.0411 0.0550
ange (g/cm) 0.0376–0.0702 0.0352–0.0442 0.0387–0.1081
tandard deviation
(SD) of g/cm values 0.0089 0.0042 0.0193
umber of animals
that differ from the
HPIV2 F control by
2 SD/total number
of animals
examined (%) 1/12 (8.3%)a 7/11 (63.6%)b
a One of 12 animals statistically different from the HPIV2 F control
ased on Student’s t test (P , 0.05).
b Of animals examined, 63.9% are statistically different from the
HPIV2 F control (P , 0.05, Student’s t test).
FIG. 2. Hematoxylin and eosin staining of the mucosa from the mouse
(white, closed arrow) and goblet cells (white, open arrow). The column
(B) SU (0.3 nmol)-treated loop with a normal number of lymphocytes
epithelium and microvilli brush-border (black, closed arrow) are unalte
SU to the intestinal loop. (C) HPIV2 F (1 nmol) protein-treated loop with an equa
open arrow). The columnar epithelium and the microvilli brush-border remainific, 0.03- to 0.45-nmol samples of purified SU were
dministered IP to 7-day-old CD-1 outbred mouse
ups (n 5 25). Diarrhea in the CD-1 pups was ob-
erved, although the instance of diarrhea was less
han that seen in the Balb/C pups (0% for the 0.03-nmol
ose, 10% for the 0.3-nmol dose, 20% for the 0.45-nmol
ose). The rate of diarrhea was similar to that ob-
erved in the Balb/C animals in that onset was within
h and persisted for up to 8 h post injection. The
everity of the diarrhea was also comparable to the
alb/C pups. CD-1 pups administered purified wt pro-
ein or PBS did not develop diarrhea. These data
ndicate that the enterotoxic effect was not specific to
alb/C pups; however, genetic make-up of the animals
ay contribute to the number of animals which expe-
ience diarrhea as seen with NSP4 (J. M. Ball and M. K.
stes, unpublished data).
U induced fluid accumulation in mouse intestinal
oops
SU was surgically introduced into 4- to 6-week-old
alb/C mouse intestinal loops to monitor protein-specific
luid accumulation. The average SU-treated loops were
.0550 g/cm compared to an average of 0.0411 and
.0467 g/cm for the HPIV2 F-treated and PBS control-
reated intestinal loops, respectively (Table 1). Seven of
1 (63.6%) of the SU-treated loops were statistically
eavier/cm as the result of an accumulation of fluid when
ompared to HPIV2 F control-treated loops (Student’s t
est, P , 0.05). The SU-treated mice often had diarrhea
uring recovery. This observation was surprising since
he SU inoculum was administered directly into the in-
estinal segments. Fluid accumulation in adult mice in-
estinal loops supports the conclusion that the SU-in-
uced diarrhea is not age-dependent, as would be ex-
al loops. (A) PBS-treated loop with a normal population of lymphocytes
elium and the microvilli brush-border are intact (black, closed arrow).
, closed arrow) and goblet cells (white, open arrow). The columnar
icating there are no histological alterations induced by the addition ofintestin
ar epith
(white
red, indl number of lymphocytes (white, closed arrow) and goblet cells (white,
ed intact (black, closed arrow).
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253SIV SU IS A VIRAL ENTEROTOXINpected, since SIV infection and enteropathy are not age-
dependent.
SU does not induce histological alterations in
intestinal loops
Upon removal of the intestinal loops in the preced-
ing study, the tissues were analyzed for the presence
of histological alterations by hematoxylin and eosin
staining (Fig. 2). The mucosa of the SU-treated intes-
tinal loops appeared identical (Fig. 2B) to the PBS-
treated and HPIV2 F control-treated loops (Figs. 2A
and 2C, respectively). Minimal accumulation of neu-
trophils was observed within and around vessels of
the mesentery in both treated and nontreated intesti-
nal tissues. The accumulation of neutrophils was con-
sidered to be a secondary result due to the manipu-
lation involved in tying off the loops and subsequent
FIG. 3. Effects of neurotensin on [Ca21]i in Fluo-4-loaded HT-29 ce
mobilized upon the addition of 5 nM neurotensin. (A) Basal [Ca21]i lev
neurotensin, maximum [Ca21]i was mobilized (600 nM). (C) The respon
ddition of the neurotensin. Basal [Ca21]i was subtracted from values
FIG. 4. SU induced a dose-dependent increase in [Ca21]i in Fluo-4-lo
nM SU, to 651 nM; and (C) 300 nM SU, to 449 nM. Basal [Ca21]i washandling during injection of SU or controls. No signif-
icant lesions or other alterations were observed within
Tthe mucosa of any specimens examined from the
treatment or control groups.
SU induced intracellular calcium mobilization in
cultured HT-29 colonic cells
A calibrated assay that measures [Ca21]i concentra-
tion in response to a stimulus was utilized to determine
whether SU elicited a Ca21-specific response in cultured,
luo-4-loaded HT-29 cells. A dose response of 1–500 nM
eurotensin was tested with the Fluo-4-loaded HT-29
ells. The optimal concentration for our system was 5 nM
eurotensin, which was used in subsequent [Ca21]i mo-
bilization studies as the positive control (Dong et al.,
1997; Bozou et al., 1989; Morris et al., 1990). HT-29 cells
express the neurotensin receptor (Dong et al., 1997).
Neurotensin (5 nM) added to Fluo-4-loaded HT-29 cells
induced a rapid and transient increase in [Ca21]i (Fig. 3).
21
ges taken from a representative experiment demonstrating [Ca21]i is
r to the addition of neurotensin (0 s). (B) At 28 s after the addition of
s transient as [Ca21]i had returned to resting levels by 147 s after the
.
T-29 cells: (A) 125 nM SU increased the [Ca21]i level to 48 nM; (B) 150
ted from values shown.lls. Ima
el prio
se wa
shown
aded Hhe onset of [Ca ]i mobilization was seen 20 s after the
addition of agonist with a maximum [Ca21]i response
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254 SWAGGERTY ET AL.(600 nM) after 28 s. [Ca21]i returned to baseline fluores-
ence levels by 147 s. The basal fluorescence (63 nM)
as subtracted from all values shown. To determine
hether SU mobilized [Ca21]i, varying doses of purified
protein (10–300 nM) were added to Fluo-4-loaded HT-29
cells and [Ca21]i levels were monitored. As shown in Fig.
, SU induced a dose-dependent increase in [Ca21]i with
125–300 nM. Addition of 125, 150, and 300 nM SU in-
creased [Ca21]i by 48, 651, and 449 nM, respectively
basal fluorescence subtracted). These data indicate the
aximal [Ca21]i was mobilized at a dose of 150 nM SU,
ince an additional increase was not seen with 300 nM
U. The differences in the effective dose between SU
nd neurotensin may be a result of the number of spe-
ific receptors on HT-29 cells, but further studies are
equired to determine the level of SU-specific receptors.
150-nM sample of HPIV2 F protein did not mobilize
Ca21]i under the same conditions (n 5 5) (data not
hown).
To further characterize the Ca21 response, the kinetics
f SU- and neurotensin-treated HT-29 cells was exam-
ned. The kinetics of the SU-induced [Ca21]i response
was similar to neurotensin, i.e., time of onset was 15 s vs
20 s, maximum [Ca21]i was reached at 30–35 s vs 28 s,
and [Ca21]i returned to baseline by 140 s vs 147 s (Fig. 5).
he 125 nM SU-treated cells were slower and variable in
he onset of the response (40–70 s) and returned to
aseline levels by 120 s (Fig. 5). HPIV2 F-treated cells did
ot respond and the intensity remained at background
evels (Fig. 5).
U increased IP3 levels in HT-29 colonic cells
A competitive radioreceptor assay was utilized to mea-
ure IP3 levels in HT-29 cells treated with SU, wt protein,
FIG. 5. Average kinetics and dose response of the calcium response
of five representative cells treated with 5 nM neurotensin (E), 125 nM
SU (3), 150 nM SU (L), 300 nM SU (F), and HPIV2 F (—). Fluorescence
intensity values are within 2 SD of the mean for all cells analyzed.neurotensin, HPIV2 F, or mock-treated. SU increased IP3
levels in a dose-dependent manner (Fig. 6). At 75 and 150
bnM SU increased IP3 levels an average of 1.3- and 1.6-
fold, respectively, above basal levels in control cells (n 5
3). Neurotensin (10 nM) served as the positive control
and increased IP3 levels 1.7-fold above basal levels.
ells treated with wt protein or 150 nM HPIV2 F protein
n 5 4) yielded IP3 levels comparable to those of mock-
reated cells (Fig. 6).
U induced Cl2 secretory currents
To fulfill the definition of an enterotoxin, Cl2 secretory
currents were measured across unstripped mouse intes-
tinal mucosa. To ensure tissue reactivity to a known
agonist, forskolin (Fsk), a cAMP agonist (Frizzell and
Morris, 1994) was added prior to the addition of purified
SU (0.2 mM) or HPIV2 F (1.5 mM) proteins. SIV SU induces
l2 secretion in mouse ileal sections as measured by
Ussing chamber. Following the addition of Fsk, purified
TABLE 2
SIV SU-Induced Chloride Currents in Mouse Intestinal Mucosa
Agonista Concentration (mM) DIsc (mA/cm2)b 6 SD n
orskolin 10 23.73 6 4.48 24
U 0.2 6.32 6 1.65 7
PIV2 F 1.5 3.44 6 2.28 7
a Forskolin was added to the apical surface. SU and HPIV2 F were
dded to both surfaces of the mucosa.
b The change in short-circuit current (DIsc) was calculated by sub-
racting the stimulated Isc from the Isc measured immediately prior to
he addition of agonist. The mean tissue conductance immediately
ollowing the buffer change (apical buffer changed from Krebs–Ringer
FIG. 6. SU induced a dose-dependent increase in IP3 levels in HT-29
cells. The x-axis is the treatment administered (all were 45 s with n 5
or 4). The y-axis is the fold increase in IP3 levels above background
levels in untreated cells. Addition of 75 and 150 nM SU increased IP3
levels 1.3- and 1.6-fold, respectively. Neurotensin (10 nM) increased IP3
levels 1.7-fold. Wt baculovirus protein and HPIV2 F did not increase IP3
levels above the basal levels.icarbonate to N-methyl-D-glucamine-Krebs sodium-free) was 23.08 6
5.96 mS/cm2 (n 5 29).
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255SIV SU IS A VIRAL ENTEROTOXINSU was added apically and basolaterally and induced a
DIsc of 23.73 6 4.48 mA/cm2 (Table 2). Addition of 1.5 mM
HPIV2 F (a 7.5-fold increase in molar concentration over
SU), both apically and basolaterally, induced a smaller
Cl2 response than that seen upon the addition of SU
(Table 2). All responses to agonist were sensitive to
bumetanide, an antagonist to the Na-K-Cl cotransporter
on the basolateral surface.
DISCUSSION
SIVmac239 is a virus derived from an infectious mo-
lecular clone that causes a fatal disease in rhesus ma-
caques clinically similar to HIV-induced AIDS (Kodama et
al., 1989; Kestler et al., 1990). We examined the role of SU
derived from SIVmac239 in the GI dysfunction and enter-
opathy associated with this group of viruses. In both
HIV/SIV-infected individuals there are cases in which no
enteric pathogen can be identified that would account for
the diarrheal disease (Heise et al., 1991, 1993b; Ullrich et
l., 1989; Lambl et al., 1996). For these cases, it has been
peculated that the virus or viral protein(s) may directly
ontribute to the GI dysfunction and diarrhea. In support
f this hypothesis, IP administration of purified HIV-1 SU
n 5 4) into suckling mice was shown to induce diarrhea
J. M. Ball and M. K. Estes, unpublished data).
In addition to the critical role of viral entry and patho-
enesis of HIV/SIV infections, SU may be important in
isease induction. The SU is noncovalently bound to the
ransmembrane (TM) protein and this weak bond is eas-
ly broken, allowing SU to dissociate from TM (Robey et
l., 1986). Free SU can induce immune-mediated killing
f uninfected target cells (Hunter and Swanstrom, 1990)
nd bind to CD41 cells, rendering them susceptible to
ntibody-dependent cellular toxicity (Lyerly et al., 1987)
r to class II restricted T-cell-mediated cytolysis (Lanza-
ecchia et al., 1988).
To address the role of SU in SIV- and HIV-related
nteropathy, we tested whether a purified SIVmac239 SU
ecombinant protein could cause diarrhea. The purified
U glycoprotein induced a dose-dependent diarrhea in
- to 8-day-old Balb/C mouse pups, caused fluid accu-
ulation in adult mouse intestinal loops in the absence
f histological alterations, mobilized [Ca21]i in cultured
olonic cells, increased IP3 levels in cultured cells, and
nduced Cl2 secretory currents in intact mouse mucosa.
hese data are consistent with the findings described for
he first viral enterotoxin, rotavirus NSP4 (Dong et al.,
997; Ball et al., 1996), and define SIV SU as the second
escribed viral enterotoxin.
The mechanism(s) of SIV/HIV enteropathy is not fully
nderstood. Inflammatory mediators such as tumor ne-
rosis factor (TNF)-a, interleukin (IL)-1b, and interferon
IFN)-g levels are increased in the intestinal mucosa
pon HIV infection and may play a role in HIV enterop-
thy (Vyakarnam et al., 1991; McGowan et al., 1994; Kotler
e
pt al., 1993). Other studies indicate that an increased
evel of TNF-a or IL-1b can induce active Cl2 secretion in
the intestine (Stockman et al., 1998; Schmitz et al., 1996;
Chang et al., 1990). Immune mediators such as TNF-a
and IFN-g are also implicated in altering tight-junction
permeability (Stockman et al., 1998; Madara and Stafford,
1989). Moreover, malabsorption, a common complication
associated with SIV/HIV infections, is also associated
with diarrhea (Heise et al., 1991, 1993a,b, 1994). Our data
showing secretory currents across the intestinal mucosa
suggest SIV SU induces a secretory diarrhea. However,
examination of duodenal forceps biopsies of HIV-in-
fected individuals suffering from diarrhea show no etio-
logical agent for active ion secretion in those patients
(Stockman et al., 1998). Instead, there is a decrease in
epithelial resistance, indicating a breakdown in the epi-
thelial barrier function or a leak flux mechanism. Addi-
tional studies are needed to fully understand the mech-
anism(s) of HIV-induced diarrhea and wasting in the
absence of an identifiable agent.
Our study examined the role of SU added to (i) the
peritoneum of 6- to 8-day-old mouse pups, (ii) the lumen
of mouse intestinal loops, (iii) the unstripped mouse
intestinal mucosa, and (iv) the media of cultured HT-29
colonic cells. In a natural, productive infection with SIV,
SU would be present inside the cell before it is trans-
ported to the cell surface. The different cellular locations
of SU could affect the overall role this protein plays in
diarrhea induction. Cells treated with extracellular SU
may respond differently from those cells undergoing a
productive viral infection, in which SU would be pro-
duced intracellularly, transported to the cell surface, and
released with viral virions. However, the free SU found
outside the cell would mimic the SU that we added
extracellularly. The mechanism of diarrhea is likely to be
multifactorial and may include factors such as the strain
of virus, route of transmission, viral load, and the immune
competency of the individual host at the time of sam-
pling. Infected cells are subject to dynamic events asso-
ciated with a productive infection that would vary greatly
from those cells treated only with SU. The purified SU
alone may be sufficient to bind to another, as yet uniden-
tified, cell surface receptor that in turn mobilizes [Ca21]i
and activates a signal transduction cascade. Shimizu
and colleagues (1999) showed that an orphan G protein-
coupled receptor can serve as a functional coreceptor
for HIV productive infection in brain-derived cells. Single-
point mutations in the Gly-Pro-Gly-Arg tip sequence in
the V3 loop domain enable these viruses to use a phy-
logenetically distant coreceptor in the absence of CXC
and/or CC coreceptors (Shimizu et al., 1999, 2000). More-
over, a different novel G protein-coupled receptor also
serves as a coreceptor for some HIV-1, HIV-2, and SIV
strains (Shimizu et al., 2000). However, a specific cholin-rgic receptor that activates the phosphoinositide (PI)
athway upon SIV SU binding is not yet known.
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256 SWAGGERTY ET AL.Our data vary with an earlier study that examined the
ability of gp120 from M- and T-tropic strains of HIV and
SIV to initiate a signal upon binding to CCR5 (Weissman
et al., 1997). The latter study concluded that binding of
CCR5 by M-tropic strains causes a calcium flux, whereas
binding by the T-tropic strains such as SIVmac239 does
not. The different results may be attributed to the differ-
ent cells used in the experiments (lymphoid vs epithe-
lial). In a recent study, Arthos and colleages (2000) dem-
onstrated recombinant HIV and SIV SU glycoproteins
mobilized [Ca21]i in human macrophages; however, SU
erived from SIVmac239 did not increase [Ca21]i in their
ystem, whereas SU from SIVPBj1.9 did. The authors
uggest the lack of [Ca21]i mobilization resulted from the
nability of SIVmac239 to replicate in macrophages. Our
ata show [Ca21]i mobilization in HT-29 intestinal cells,
which were previously shown to support HIV-1 and HIV-2
infections (Yahi et al., 1992; Kagnoff and Roebuck, 1999).
However, it is not known whether HT-29 cells support
SIVmac239 replication.
We demonstrated that SU induced a transient flux in
[Ca21]i and increased IP3 levels in cultured colonic cells.
eurotensin, a neuropeptide that causes a transient in-
rease in [Ca21]i levels mediated by PI turnover, also
obilized [Ca21]i and increased IP3 levels in our system.
Given that SIV SU induces [Ca21]i mobilization, increases
IP3 levels, and stimulates Cl
2 secretion, we propose that
hospholipase C (PLC) and a PI signaling pathway are
ctivated. PI turnover as a mechanism of calcium and IP3
increase is in agreement with the NSP4 viral enterotoxin
(Dong et al., 1997).
Calcium is important in many aspects of the virus life
cycle and was shown to contribute to retrovirus-induced
disease. HIV-1 SU mobilizes [Ca21]i from caffeine-sensi-
tive stores in HT-29-D4 cells (Dayanithi et al., 1995).
Additional evidence to suggest that Ca21 contributes to
lentivirus pathogenesis is supported by the fact that
HTLV-1- and SIV-infected cells display an increase in
[Ca21]i (Wright and Olsen, 1989). Diop and colleagues
1995) reported that HIV-1 SU is toxic for neurons in
ulture in a dose-dependent manner and that toxicity
orresponds with a rise in [Ca21]i. Taken together, these
findings clearly suggest that alterations in [Ca21]i are
part of the mechanism of SIV and/or HIV disease. SIV
SU-induced [Ca21]i mobilization suggests a role for a
calcium-dependent signal transduction pathway that, in
turn, may alter intestinal epithelial transport and contrib-
ute to the diarrhea and wasting seen in SIV and/or HIV
infections. However, the precise role of calcium in enter-
opathy is yet to be determined.
The presence of a viral enterotoxin in SIV and/or HIV
viruses offers one explanation for the GI dysfunction
often associated with these viral infections. This expla-
nation is not intended to discount or replace those in-
stances in which the GI disorders are associated with an
identifiable enteric pathogen. However, it is feasible that
m
athe SU enterotoxin and known enteric pathogens are
both contributing to the wasting syndrome seen in HIV/
SIV-infected individuals. Consistent with other HIV/SIV
pathogenic events, the mechanism(s) of viral enteropa-
thy is likely complex, combining Ca21 flux, immune me-
diators, and the PI signaling pathway.
Identification of SU as a viral enterotoxin enables di-
rect testing of this mechanism of SU-induced diarrhea
and allows for the development of potential therapeutics
directed at preventing or controlling the devastating
wasting/enteropathy associated with this group of vi-
ruses.
MATERIALS AND METHODS
Cell culture
Spodoptera frugiperda (Sf9) insect cells, a gift from Dr.
M. K. Estes (Baylor College of Medicine, Houston, TX)
were maintained in suspension at 26°C in SF-900 II
serum-free media (Gibco BRL Products, Gaithersburg,
MD) containing 100 units of penicillin (Sigma Chemical,
St. Louis, MO) and 10 mg/ml streptomycin (Sigma), and
were rotated at 85–90 rpm. Sf9 cells were used to grow
baculovirus stocks and for baculovirus recombinant pro-
tein expression. HT-29 cells, human colon adenocarci-
noma (ATCC, Rockville, MD), were maintained in 90%
McCoy’s 5a medium supplemented with 2 mM L-glu-
amine, 0.1 mM nonessential amino acids, 100 units of
enicillin, 10 mg/ml streptomycin, and 10% fetal bovine
erum (FBS; HyClone Laboratories, Logan, UT) in a hu-
id environment at 37°C with 5% CO2.
Baculovirus stocks
Wildtype (wt) baculovirus, Autographa californica nu-
clear polyhedrosis virus (AcNPV), was provided by Dr.
M. K. Estes. Generation of the SU baculovirus recombi-
nant has previously been described (Yamshchikov et al.,
995). Briefly, the env gene was placed under the control
f a hybrid capsid/polyhedrin promoter (Pcap/polh) and
ntroduced into Sf9 cells with AcNPV. Those recombi-
ants that expressed the env gene were selected by
laque assay and subsequently analyzed by PCR.
The vector pBlueBac4.5 (Invitrogen, San Diego, CA)
as used for construction of the recombinant baculovi-
us expressing the soluble human parainfluenza-2 fusion
rotein (HPIV2 F) (Tong and Compans, 2000). The pBlue-
ac4.5 plasmid contains the early-to-late promoter and
he very late polyhedrin promoter from AcNPV. A DNA
ragment encoding a soluble HPIV2 F protein was am-
lified by PCR from the pGEM-3-PI2 F template de-
cribed by Hu et al. (1990). The sense primer consisted
f an oligonucleotide corresponding to sequences up-
tream of the HPIV2 F protein coding sequence with a
odification to include a BamHI restriction site. The
ntisense primer corresponded to nucleotides
d
V
S
w
P
f
p
e
g
(
f
F
c
a
R
m
m
a
c
B
a
&
a
s
t
a
M
u
a
m
b
i
(
P
t
C
c
e
a
M
(
L
A
257SIV SU IS A VIRAL ENTEROTOXIN1626–1612 of the pGEM-3-PI2 F plasmid with an intro-
duction of a stop codon and an EcoRI restriction site. The
resultant PCR fragment was digested with BamHI and
EcoRI and was then ligated into the pBlueBac4.5 plasmid
digested with BamHI and EcoRI. The recombinant clone
was sequenced to ensure that the correct clone was
obtained.
Sf9 cells were cotransfected with Bac-N-Blue DNA
and the vector pBlueBac4.5 encoding the soluble HPIV2
F protein using a MaxBac 2.0 Transfection kit (Invitro-
gen). After a 5-day incubation, the media containing
recombinant viruses were collected and a plaque assay
was performed according to the Invitrogen instruction
manual. Recombinant virus plaques that did not contain
occlusion bodies and showed blue color were selected
and were screened by PCR amplification to determine
which plaque had the expected size of the PCR products.
The selected plaques were subjected to four rounds of
plaque purification. Baculovirus recombinants express-
ing soluble HPIV2 F are designated as rBV-HPIV2 F9.
SU and HPIV2 F recombinant and wt baculovirus
stocks were grown in Sf9 cells by infecting 3 3 106
cells/ml at a multiplicity of infection (m.o.i.) of 0.1. The
supernatant from the infected cells was harvested 5–7
days postinfection and the cell debris was removed by
centrifugation at 830 g for 10–15 min. Virus titers were
etermined by plaque assays as previously described by
olkman and Summers (Volkman and Summers, 1975;
ummers and Smith, 1976, 1988). All baculovirus stocks
ere stored at 4°C.
rotein expression, purification, and characterization
SU or wt baculovirus proteins were expressed by in-
ecting 2 3 106 Sf9 cells/ml at a m.o.i. of 1. The super-
natant was harvested 24, 48, or 72 h postinfection. HPIV2
F protein was expressed by infecting 2 3 106 Sf9 cells/ml
at a m.o.i. of 2 and harvested after 72 h. Intact cells
and/or cell debris were separated from soluble proteins
by centrifugation at 830 g for 15–20 min. The baculovirus
virions were removed by ultracentrifugation at 75,000 g.
The supernatant containing soluble proteins was col-
lected and passed through a Nalgene Maxi Centrifuge
Filter (Nalge Nunc International, Rochester, NY) with a
30-kDa molecular weight cutoff. The filter apparatus was
transferred to a 50-ml conical tube (Corning, Oneonta,
NY) and centrifuged at 3000 g until 2–3 ml of solute
remained. A single filter was used to collect each time
point. Once the protein was concentrated onto the filter,
the filter apparatus was removed, inverted into a new
50-ml conical tube, and centrifuged at 3000 g for 30 min
to remove the protein from the membrane of the filter
apparatus. A 1-mg sample of SU and wt baculovirus
rotein was loaded onto a 12% polyacrylamide gel and
lectrophoresed at 150 V for approximately 1.5 h. The SU
el was stained with GelCode Blue Stain Reagent
sPierce Chemical, Rockford, IL) according to the manu-
acturer’s instructions (Fig. 7A). A 1-mg sample of HPIV2
protein was loaded onto a 10% polyacrylamide gel
ontaining 5 M urea, electrophoresed at 150 V for 1.5 h,
nd stained with Coomassie Brilliant Blue G-250 (Bio-
ad Laboratories, Hercules, CA) (Fig. 7B). The estimated
olecular weight of HPIV2 F was 54 kDa. The estimated
olecular weight of SU was determined to be 80 kDa
nd purity was estimated to be 80%. Purity of SU was
onfirmed by HPLC analysis (Beckman System Gold;
eckman Instruments, Fullerton, CA), by use of a C4
nalytical column (Waters C4 Delta Pak column; Waters
Associates, Milford, MA), a linear gradient of water and
cetonitrile, and integration of the peaks (data not
hown). Contaminating proteins were controlled for in
he wt and HPIV2 F controls. SU, wt baculovirus protein,
nd HPIV2 F concentrations were determined by the
icro BCA Protein Assay Reagent Kit according to man-
facturer’s instructions and were estimated to be 1.3, 0.4,
nd 7 mg/ml, respectively (Pierce Chemical). The micro-
olar concentration of the wt baculovirus was unable to
e determined, since molecular weights of contaminat-
ng proteins were unknown; therefore, an equal amount
in micrograms) was administered. Purified protein and
BS were assayed for the presence of endotoxin using
he Limulus Amebocyte Lysate (LAL) test (Associates of
ape Cod, Falmouth, MA) in endotoxin-free tubes ac-
ording to the manufacturer’s protocol. A value of 0.5
ndotoxin units (EU)/ml or less was considered accept-
ble for use in our experiments.
ouse inoculation and diarrhea scoring
Balb/C mice, acquired from Harlan Sprague–Dawley
Indianapolis, IN), and CD-1 mice, from Charles River
aboratories (Wilmington, MA), were housed at Texas
&M University Laboratory Animal Resources and Re-
FIG. 7. (A) SDS–PAGE of purified SU and wt proteins. Lane 1, molec-
ular weight markers; lane 2, wt protein; lane 3, SIV SU. Arrow indicates
SU protein. The estimated purity of SU is 80%. (B) SDS–PAGE of purified
HPIV2 F protein. Lane 1, molecular weight markers; lane 2, HPIV2 F
protein. Arrow indicates HPIV2 F protein.earch Facility. Purified SU was diluted to 50 ml in sterile,
endotoxin-free PBS and was injected intraperitoneally
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258 SWAGGERTY ET AL.(IP) into 6- to 8-day-old pups using a 30G needle. To
determine whether the diarrheal response was dose-
dependent, 0.01 to 0.45 nmol of SU was administered to
54 pups. Wt baculovirus (28.9 mg) and HPIV2 F (1 nmol)
supernatants were prepared identically to SU and served
as negative controls. Following injection, the pups were
monitored for diarrhea every 2 h for 10 h and then again
at 24 h post injection. The pups were monitored by one
person who scored the diarrhea on a scale of 1 to 4 as
previously described (Ball et al., 1996).
Intestinal loops
To determine whether SU would induce fluid accumu-
lation in closed intestinal segments, SU protein was
surgically introduced into mouse intestinal loops. Four-
to 6-week-old Balb/C mice were fasted for 3–5 h, and
anesthetized with IsoFlo isoflurane, USP (Abbott Labora-
tories, North Chicago, IL). An incision was made in the
abdomen, the intestines exposed, and a short segment
of the intestine (ileum and a portion of the jejunum) was
tied off using two coated 4-0 Vicryl polyglactin sutures
(Ethicon, Somerville, NJ). Eleven animals were adminis-
tered 50 ml of 0.30 nmol SU dissolved in sterile, endo-
oxin-free PBS. A total of 16 animals received either 50 ml
BS or 1 nmol HPIV2 F protein and served as the neg-
tive control. The incision was sutured closed and mice
ere isolated and kept warm for the 3-h recovery period,
t which point they were humanely terminated; the in-
estinal loops were removed and weighed, and their
ength was measured. A ratio of weight (g) to length (cm)
as calculated for the SU-treated loops and then com-
ared to the g/cm ratio of control loops.
istological analysis
To determine whether SU induced histological alter-
tions within the intestinal loop, sections of each loop
ere analyzed for any changes. Upon completion of the
hysical measurements, the intestinal loops were at-
ached to a corkboard and fixed by immersion in 10%
eutral buffered Formalin for 24 h. An unmanipulated
egment of intestine not included in the intestinal loop
as removed to serve as the animal control. Represen-
ative sections of the jejunum and the ileal loop were
rimmed, placed in Path Cassette IV tissue cassettes
Curtis Matheson Scientific, Houston, TX), and processed
n a Shandon Hypercenter 2 (Shandon, Pittsburgh, PA).
amples were subjected to dehydration through graded
lcohols (70%, 80%, 95%, absolute) to xylene, then infil-
rated with Paraplast paraffin (Fisher, Pittsburgh, PA).
fter being processed the tissues were embedded on
nd in paraffin blocks utilizing a Tissue-Tek console
Miles Scientific, Elkhart, IN). Coronal sections (3–5 mi-
rons) of each tissue were cut on a Leitz Model 1512
otary microtome (Ernst Leitz Wetylan GMBH, Austria),
loated in a water bath, collected on glass slides, depar-
effinized, then rehydrated through graded alcohols (ab-
olute, 95%, 80%, 70%). Each section was stained with
nstant hematoxylin (Shandon) and eosin (Sigma) and
overslipped with Permount mounting media (Fisher Sci-
ntific, Fairlawn, NJ) for microscopic examination utiliz-
ng an Olympus BH-2 microscope (Olympus Optical,
okyo, Japan).
oading HT-29 cells with Fluo-4 for calcium imaging
HT-29 cells were seeded at 1.0 3 106 cell/ml into
LAB-TEK two-well chamber slides with coverglass slides
(2 ml/well; Nalge Nunc International) and allowed to
grow for 12–16 h. Cells were loaded using the following
modified protocol (Scheenen et al., 1998). The growth
medium was removed and replaced with a physiological
calcium-free buffer (PCFB: 150 mM NaCl, 5 mM KCl, 10
mM glucose, 20 mM HEPES, 1 mM MgCl) (Steinberg et
al., 1987) and incubated for 10–15 min at 37°C, 5% CO2.
The buffer was removed and the cells were loaded with
1 ml PCFB containing 3% FBS, 1 mM Fluo-4 (Molecular
robes, Eugene, OR), and 0.02% Pluronic F-127 (Sigma).
he dye solution was allowed to incubate on the cells for
0 min at room temperature to minimize compartmental-
zation of the dye. The dye was then removed from the
ells, the cells were rinsed twice with PCFB, and 0.5 ml
f the PCFB was added to the cells for an additional
0-min incubation at room temperature. The FBS was
ound to inhibit SU [Ca21]i mobilization and was therefore
emoved once the dye had been loaded into the cells. SU
nd either neurotensin (positive control) or HPIV2 F (neg-
tive control) were added to 0.5 ml PCFB and added to
he cells immediately prior to analysis.
onfocal fluorescence microscopy
The calcium imaging studies were performed on an
RC-1024 laser scanning confocal imaging system con-
rolled by LaserSharp software (Bio-Rad). The system
as based on the Zeiss Axiovert 135 microscope and
quipped with three independent low-noise photo-multi-
lier tube channels. The excitation light (l 488 nm) from
15-mW krypton-argon laser (5 mW all lines, measured
t the microscope stage) was delivered to the sample
hrough a 63X Zeiss Plan-Fluor oil immersion objective
ith a numerical aperture of 1.45. A region of 10–20 cells
as randomly selected and the objective positioned to
iew the median section of the cells. The calcium kinet-
cs was monitored on single cells by digitally acquiring
mages at 7-s intervals and calculating the average pixel
ntensity using the Time Course Software (Bio-Rad).
P3 measurements
The IP3 assay was performed as previously described
ith the following modifications (Dong et al., 1997; Bozou
t al., 1989; Mutoh et al., 1999). Briefly, HT-29 cells were
seeded into six-well plates and allowed to grow to con-
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259SIV SU IS A VIRAL ENTEROTOXINfluency. The media was removed from the cells and the
cells were washed with 10 mM lithium chloride (LiCl) for
30 s to remove excess media. The cells were then
incubated with 10 mM LiCl at 37°C for 10 min with gentle
shaking to inhibit inositol-1-phosphatase. The LiCl was
discarded and the cells were either mock-treated or
treated for 45 s with 75 nM SU, 150 nM SU, wt baculo-
virus protein (43.3 mg) or 150 nM HPIV2 F (negative
ontrols), or 10 nM neurotensin (positive control), pre-
ared in Na/HEPES-buffered saline (140 mM NaCl, 4.7
M KCl, 1.13 mM MgCl2, 10 mM HEPES, 10 mM glucose,
mM CaCl2). Basal levels were determined by treating
he cells with Na/HEPES-buffered saline for 45 s. The
eaction was stopped with 0.2 to 0.3 volumes of ice-cold
0% perchloric acid and the cells were removed from the
late by scraping, transferred to a 1.5-ml tube, sonicated
or 2 min, and incubated on ice for 20 min. The sample
as then centrifuged at 16,000 g at 4°C for 15 min, and
he supernatant was transferred to a new tube and neu-
ralized with 10 M KOH. A precipitate formed, which was
emoved by centrifugation at 16,000 g at 4°C for 15 min,
nd the supernatant was then transferred to a siliconized
ube and assayed for IP3 by a competitive radioreceptor
assay (TRK1000; Amersham Pharmacia Biotech, Piscat-
away, NJ) according to the manufacturer’s instructions.
Briefly, standards were prepared fresh for each assay
and used within 1 h of preparation. Samples were diluted
in the assay buffer, to which diluted tracer and binding
protein were added. The sample was vortexed and incu-
bated on ice for 15 min. Samples and standards were
then centrifuged at 4°C for 15 min at 16,000 g, at which
point the supernatant was discarded and the pellet re-
suspended in water and incubated at room temperature
for 10 min. The samples were then decanted immediately
into scintillation vials containing 5 ml CytoScint scintilla-
tion fluid (ICN Biomedicals, Irvine, CA) and mixed, and
the radioactivity was measured for 4 min in a 1600 TR
Tri-Carb liquid scintillation analyzer (Packard Instrument
Company, Downers Grove, IL).
Cl2 secretory current measurements
To determine whether SU induced Cl2 secretory cur-
ents across intact mouse mucosa, 18- to 23-day-old
alb/C mice were euthanized by overdosing with IsoFlo
soflurane. The peritoneal cavity was opened and the
leum located. Approximately 4 cm of ileum was removed
nd cut longitudinally into segments 6–8 mm long, and
ounted unstripped between pieces of Kimwipes EX-L
xtra-low-lint wipers (Kimberly-Clark, Atlanta, GA) onto
icro-Ussing chamber sliders (aperture of 0.04 cm2). The
tissues were then equilibrated at 37°C for 30 min in
Krebs–Ringer bicarbonate buffer [115 mM NaCl, 4.7 mM
KCl, 1.13 mM MgCl2, 10 mM glucose, 1.15 mM Na2H2PO4
(anhydrous), 25 nM NaHCO3] and gassed with 95%
O2/5% CO2 throughout the experiment. The short-cir-uited current (Isc) required to nullify the spontaneous
transepithelial potential difference was monitored con-
tinuously with an automatic voltage clamp (Physiological
Instruments, San Diego, CA). To minimize the effects on
Isc of cAMP-stimulated, electrogenic Na
1-glucose co-
ransport across the intestinal cells (Grubb, 1995), the
pical (mucosal) bath was changed to N-methyl-D-gluca-
mine (NMDG)–Krebs sodium-free buffer (120 mM NMDG,
1.13 mM MgCl2, 4.7 mM KCl, 10 mM glucose, 1 nM
KH2PO4, 25 mM choline bicarbonate ([2-hydroxyethyl]
trimethyl-ammonium; Sigma) prior to challenge. After
temperature and ionic equilibration were reestablished,
tissues were challenged with a known agonist: 10 mM
oleus forskohlii in dimethyl sulfoxide (forskolin [FSK];
albiochem, San Diego, CA). Once the response of the
nown agonist was established, the unstripped mucosa
as treated with 0.2 mM SU or 1.5 mM HPIV2 F protein.
he changes in transepithelial electrical current that
ere induced by anion flux were measured as Isc. Bu-
etanide (Calbiochem) sensitivity (400 mM prepared in
dimethyl sulfoxide) confirmed that the anionic flux being
measured was caused by the chloride secretory re-
sponse (Frizzell and Morris, 1994).
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